OVOL1 rs4798812: Genetics and Eczema Susceptibility
The genetic variant rs4798812 is a single-nucleotide polymorphism located near the OVOL1 gene on human chromosome 11. Genome-wide association studies have identified this variant as statistically associated with susceptibility to atopic dermatitis, commonly known as eczema. However, the evidence strength is currently classified as limited, indicating it modifies risk subtly alongside many other genetic and environmental factors.
What each genotype means
Baseline atopic dermatitis risk
This genotype represents the common genetic background at this position in the OVOL1 gene. Research indicates that this variant is associated with susceptibility to atopic dermatitis, but carrying this specific combination does not imply a diagnosis. Atopic dermatitis is a complex condition influenced by many genetic and environmental factors.
This genotype is common in many populations, though exact frequencies vary significantly by ancestry.
Increased atopic dermatitis susceptibility
Individuals with this genotype carry one copy of the variant associated with atopic dermatitis in genome-wide association studies. While this variant is linked to skin barrier function and immune regulation, it is only one of many factors that contribute to the development of eczema. Please consult with a dermatologist if you have concerns about skin health.
This heterozygous genotype is frequently observed in European populations, where the minor allele frequency is approximately 0.30 to 0.40.
Higher atopic dermatitis susceptibility
This genotype includes two copies of the variant associated with an increased risk of atopic dermatitis. The OVOL1 gene plays a role in skin cell differentiation, and variations here may influence skin barrier integrity. This association is based on statistical population studies and does not guarantee the development of any skin condition.
This homozygous genotype is present in a significant portion of the population, particularly among those of European ancestry.
Genomic Context and Identity of rs4798812
The single-nucleotide polymorphism rs4798812 is situated on chromosome 11 in close proximity to the OVOL1 locus. In human genetics, common variants like rs4798812 represent positions where individuals carry different DNA nucleotides, typically categorized by C and T alleles. Rather than changing a protein's coding sequence directly, this variant lies in a non-coding regulatory genomic region. Such regulatory variations often act by subtly tuning the expression levels or timing of nearby genes rather than disrupting the primary structure of cellular proteins. Research catalogs such as dbSNP curate these exact genomic coordinates to help investigators track how regulatory variation contributes to human phenotypic diversity.
The Biological Function of the OVOL1 Gene
The OVOL1 gene encodes ovo-like transcriptional repressor 1, a zinc-finger transcription factor essential for epithelial differentiation and cutaneous barrier integrity. Within human epidermal keratinocytes, OVOL1 acts downstream of key environmental and signaling pathways, including the aryl hydrocarbon receptor (AhR) axis, to govern terminal differentiation and the expression of barrier proteins like filaggrin and loricrin. When OVOL1 function or regulation is impaired, keratinocyte maturation can be perturbed, leading to compromised epidermal barrier defense and heightened susceptibility to cutaneous inflammatory cascades. Animal and cell-based studies consistently demonstrate that functional OVOL1 signaling maintains the balance between cellular proliferation and barrier formation in healthy skin.
GWAS Evidence and Eczema Susceptibility
In large-scale genome-wide association studies (GWAS), rs4798812 and its linked genomic region have been repeatedly flagged for statistical associations with atopic dermatitis (atopic eczema). Atopic dermatitis is a multifactorial inflammatory skin disorder shaped by complex interactions between skin barrier disruption and immune dysregulation. Current scientific evidence classifies the association of rs4798812 with atopic dermatitis as limited to moderate in effect size. This variant is not a deterministic cause of eczema; instead, possessing a risk-associated allele confers a modest statistical shift in lifetime susceptibility. Like most complex traits discovered through GWAS, atopic dermatitis risk is distributed across dozens to hundreds of distinct genetic loci.
Population Distribution and Ancestry Patterns
Allele frequencies for rs4798812 vary across different global populations. In European ancestries, catalog data and reference repositories such as gnomAD record a minor allele frequency of approximately 0.30 to 0.40. Frequencies can differ significantly among other world populations, including East Asian, African, and admixed cohorts. Because many initial dermatological GWAS were heavily enriched for participants of European descent, the predictive transferability and relative effect sizes across diverse global ancestries remain an active area of ongoing investigation, highlighting the importance of cautious interpretation when applying generalized findings across varied genetic backgrounds.
Clinical Realities: What This Information Means for You
Learning your rs4798812 genotype offers biological curiosity rather than a clinical diagnosis. Carrying an associated risk allele does not mean an individual will inevitably develop eczema, just as carrying non-risk alleles does not guarantee immunity from skin inflammation. Genetic testing for non-coding variants like rs4798812 cannot replace a clinical evaluation by a dermatologist or primary care provider. Furthermore, this genetic marker does not dictate responses to specific topical or systemic medications; any preventive skin barrier care, topical therapies, or prescription adjustments must always be managed in consultation with a qualified medical professional.
How common is this variant?
The minor allele frequency for rs4798812 ranges between approximately 0.30 and 0.40 in European populations, with differing frequencies observed across other ancestral backgrounds in global databases like gnomAD.
Frequently asked questions
Does having the rs4798812 risk allele mean I will get eczema?
No, it does not. Atopic dermatitis is a polygenic condition influenced by numerous genetic variants as well as climate, allergens, and skin barrier exposures. Carrying the variant only reflects a slight statistical difference in population risk, not a certainty of disease.
What is the biological role of the OVOL1 gene in human skin?
OVOL1 produces a transcription factor that helps regulate the proper maturation of keratinocytes, the primary cells of the outer skin layer. It supports the expression of structural proteins necessary for keeping the skin barrier sealed and resilient against irritants.
Can testing rs4798812 guide my eczema medication choices?
No, rs4798812 is not an actionable pharmacogenomic marker and is not recognized by dosing guidelines such as CPIC. You should never alter your skincare regimen, topical treatments, or systemic medications without direct guidance from your doctor or pharmacist.
Why is the evidence for rs4798812 classified as limited?
Although genome-wide association studies show a statistically valid signal near OVOL1, individual non-coding variants have small isolated effect sizes. Furthermore, functional biological validation across diverse ancestry groups is still developing, warranting measured interpretation.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4798812?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29